Global overview on available assays for screening and treatment options for cervical cancer

The presentation outlined WHO’s global strategy to eliminate cervical cancer, aiming for an incidence below four per 100,000 women through 90-70-90 targets by 2030. It traced the evolution of WHO guidelines (2011–2021), emphasizing HPV DNA testing, ablative treatments (cryotherapy, thermal ablation), and simplified screen-and-treat algorithms. Distinctions for women living with HIV include earlier and more […]

>